365 related articles for article (PubMed ID: 15242977)
1. Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration.
Ashton AW; Ware JA
Circ Res; 2004 Aug; 95(4):372-9. PubMed ID: 15242977
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 receptor agonists antagonize the proangiogenic effects of fibroblast growth factor-2: role of receptor internalization, thrombospondin-1, and alpha(v)beta3.
Ashton AW; Cheng Y; Helisch A; Ware JA
Circ Res; 2004 Apr; 94(6):735-42. PubMed ID: 14963009
[TBL] [Abstract][Full Text] [Related]
3. Activation of NAD(P)H oxidases by thromboxane A2 receptor uncouples endothelial nitric oxide synthase.
Zhang M; Song P; Xu J; Zou MH
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):125-32. PubMed ID: 20947827
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2).
Ashton AW; Yokota R; John G; Zhao S; Suadicani SO; Spray DC; Ware JA
J Biol Chem; 1999 Dec; 274(50):35562-70. PubMed ID: 10585431
[TBL] [Abstract][Full Text] [Related]
5. Reversal of angiogenesis in vitro, induction of apoptosis, and inhibition of AKT phosphorylation in endothelial cells by thromboxane A(2).
Gao Y; Yokota R; Tang S; Ashton AW; Ware JA
Circ Res; 2000 Oct; 87(9):739-45. PubMed ID: 11055976
[TBL] [Abstract][Full Text] [Related]
6. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation of phosphatidylinositol 3-kinase and of the thromboxane A2 (TXA2) receptor by the TXA2 mimetic I-BOP in A7r5 cells.
Morinelli TA; Finley EL; Jaffa AA; Kurtz DT; Ullian ME
Biochem Pharmacol; 1997 Jun; 53(12):1823-32. PubMed ID: 9256157
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane A2 receptor activates a Rho-associated kinase/LKB1/PTEN pathway to attenuate endothelium insulin signaling.
Song P; Zhang M; Wang S; Xu J; Choi HC; Zou MH
J Biol Chem; 2009 Jun; 284(25):17120-17128. PubMed ID: 19403525
[TBL] [Abstract][Full Text] [Related]
9. Physiological significance of thromboxane A(2) receptor dimerization.
Sasaki M; Miyosawa K; Ohkubo S; Nakahata N
J Pharmacol Sci; 2006 Apr; 100(4):263-70. PubMed ID: 16565578
[TBL] [Abstract][Full Text] [Related]
10. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
11. Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species.
Wilson SJ; Cavanagh CC; Lesher AM; Frey AJ; Russell SE; Smyth EM
J Lipid Res; 2009 Jun; 50(6):1047-56. PubMed ID: 19151335
[TBL] [Abstract][Full Text] [Related]
12. Different pathways for activation of extracellular signal-regulated kinase through thromboxane A2 receptor isoforms.
Miyosawa K; Sasaki M; Ohkubo S; Nakahata N
Biol Pharm Bull; 2006 Apr; 29(4):719-24. PubMed ID: 16595906
[TBL] [Abstract][Full Text] [Related]
13. Regulation of extracellular signal-regulated kinase cascades by alpha- and beta-isoforms of the human thromboxane A(2) receptor.
Miggin SM; Kinsella BT
Mol Pharmacol; 2002 Apr; 61(4):817-31. PubMed ID: 11901221
[TBL] [Abstract][Full Text] [Related]
14. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway.
Chavakis E; Dernbach E; Hermann C; Mondorf UF; Zeiher AM; Dimmeler S
Circulation; 2001 Apr; 103(16):2102-7. PubMed ID: 11319202
[TBL] [Abstract][Full Text] [Related]
15. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
Pfister SL; Pratt PE; Kurian J; Campbell WB
Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species.
Michaud SE; Dussault S; Groleau J; Haddad P; Rivard A
J Mol Cell Cardiol; 2006 Aug; 41(2):275-84. PubMed ID: 16806264
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane binding and signal transduction in rat glomerular mesangial cells.
Spurney RF; Onorato JJ; Albers FJ; Coffman TM
Am J Physiol; 1993 Feb; 264(2 Pt 2):F292-9. PubMed ID: 8447439
[TBL] [Abstract][Full Text] [Related]
18. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen.
Grosser T; Zucker TP; Weber AA; Schulte K; Sachinidis A; Vetter H; Schrör K
Eur J Pharmacol; 1997 Jan; 319(2-3):327-32. PubMed ID: 9042608
[TBL] [Abstract][Full Text] [Related]
19. The isoprostane 8-iso-PGF2alpha suppresses monocyte adhesion to human microvascular endothelial cells via two independent mechanisms.
Kumar A; Kingdon E; Norman J
FASEB J; 2005 Mar; 19(3):443-5. PubMed ID: 15640282
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
Lin MT; Yen ML; Lin CY; Kuo ML
Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
